Tolerability of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2+advanced breast cancer : Abstract #4120
Fátima CardosoJ-L CanonD. AmadoriLuc DirixE. VillaD. AldrighettiJean‐Pascal MachielsLev VerkhXin HuangC. Giorgetti
1
Citation
0
Reference
0
Related Paper
Keywords:
Tolerability
Cite